{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:12:12Z","timestamp":1761559932175},"reference-count":43,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":3385,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[2003,12]]},"abstract":"<jats:p>The clinical outcome of duodenal ulcer treated with proton pump inhibitor (PPI)\u2013based, anti\u2014Helicobacter pylori (H.p.) regimens varies according to cytochrome P450 2C19 (CYP2C19) genotype. CYP2C19 genotypes differ markedly in peoples of Pacific Rim descent compared with another ethnicity. The authors sought to determine the specific impact that these factors have on the cost\u2010effectiveness of duodenal ulcer management. Their model consisted of two patient cohorts with Helicobacter pylori and duodenal ulcer, trichotomized into CYP2C19 homozygous extensive metabolizers (EMs), heterozygous EMs, and poor metabolizers (PMs), altering the anti\u2010H.p. regimen in the genotyped cohort only. The authors took the perspective of a third\u2010party payer, and the denominator was ulcer episode prevented. In the reference case, the use of CYP2C19 genotyping prior to initiating anti\u2010H.p. therapy was dominant (costs were saved with each ulcer episode prevented) in all geographic regions of the United States. The subsequent break\u2010even analysis showed a range of $89.20 to $118.96\u2014from Hawaii to the Midwest, respectively\u2014required to eliminate the cost\u2010savings from each genotype test performed. Using probabilities most unfavorable to genotyping, the variation of peoples with Pacific Rim origins from 0% to 100% altered the cost\u2010effectiveness from $495 to $2125 per ulcer event prevented, respectively. The results suggest that treatment decisions for H.p. infection that are based on a patient's CYP2C19 genotype decreases expenses for health plans implementing testing. This analysis provides an economic basis to support recent calls to expand this technology into routine clinical care to prevent toxicity of narrow therapeutic index drugs.<\/jats:p>","DOI":"10.1177\/0091270003259389","type":"journal-article","created":{"date-parts":[[2003,11,13]],"date-time":"2003-11-13T22:33:45Z","timestamp":1068762825000},"page":"1316-1323","source":"Crossref","is-referenced-by-count":27,"title":["Polymorphisms and the Pocketbook: The Cost\u2010Effectiveness of Cytochrome P450 2C19 Genotyping in the Eradication of <i>Helicobacter pylori<\/i> Infection Associated with Duodenal Ulcer"],"prefix":"10.1002","volume":"43","author":[{"given":"David F.","family":"Lehmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.","family":"Medicis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia D.","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02282317"},{"key":"e_1_2_5_3_2","first-page":"246","article-title":"The influence of drug dosage on Helicobacter pylori eradication: a cost\u2010effectiveness analysis","volume":"91","author":"Treiber G","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-136-1-200201010-00008"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1992.tb00556.x"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.1.39"},{"key":"e_1_2_5_7_2","first-page":"1195","article-title":"Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S\u2010mephenytion 4\u2032\u2010hydroxylation recruited from an Oriental population","volume":"262","author":"Sohn DR","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)70075-5"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-12-199812150-00006"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02282317"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200008033430501"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.1.54"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199704103361503"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1005698"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.304.6820.143"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)70017-2"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.113959"},{"key":"e_1_2_5_18_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/archinte.1997.00440220091012","article-title":"Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori","volume":"157","author":"Taylor JL","year":"1997","journal-title":"Arch Intern Med"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199302043280503"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011035007591"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01108.x"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(01)28055-2"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2000.106826"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(98)90142-4"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1985.tb02673.x"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1992.38"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9236(95)90053-5"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.126"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1985.194"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199504000-00002"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050488"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.117"},{"key":"e_1_2_5_33_2","unstructured":"http:www.census.govpopulationwwwsocdemoraceapi99.html."},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00541938"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1984.256"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9236(95)90228-7"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199612000-00005"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199702000-00008"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199608000-00006"},{"key":"e_1_2_5_40_2","unstructured":"http:hcup.ahrq.govHCUPnet.asp."},{"key":"e_1_2_5_41_2","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond MF","year":"1997"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-132-4-200002150-00003"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105033441811"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.18.2270"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1177%2F0091270003259389","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1177\/0091270003259389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:30:09Z","timestamp":1697229009000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1177\/0091270003259389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["10.1177\/0091270003259389"],"URL":"https:\/\/doi.org\/10.1177\/0091270003259389","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}